| 000 | 01642 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250518080445.0 | ||
| 264 | 0 | _c20210609 | |
| 008 | 202106s 0 0 eng d | ||
| 022 | _a1875-5631 | ||
| 024 | 7 |
_a10.2174/1566523220666200107151025 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aTsagkaris, Christos | |
| 245 | 0 | 0 |
_aGene Therapy for Angelman Syndrome: Contemporary Approaches and Future Endeavors. _h[electronic resource] |
| 260 |
_bCurrent gene therapy _c2020 |
||
| 300 |
_a359-366 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 |
_aAngelman Syndrome _xgenetics |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAnti-Anxiety Agents _xpharmacology |
| 650 | 0 | 4 |
_aAntiparkinson Agents _xpharmacology |
| 650 | 0 | 4 |
_aBuspirone _xpharmacology |
| 650 | 0 | 4 | _aDiet, Ketogenic |
| 650 | 0 | 4 | _aDietary Supplements |
| 650 | 0 | 4 | _aDisease Models, Animal |
| 650 | 0 | 4 | _aGene Silencing |
| 650 | 0 | 4 | _aGenetic Therapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLevodopa _xpharmacology |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 |
_aMinocycline _xpharmacology |
| 650 | 0 | 4 |
_aNeurons _xmetabolism |
| 650 | 0 | 4 | _aSignal Transduction |
| 650 | 0 | 4 |
_aTopoisomerase I Inhibitors _xpharmacology |
| 650 | 0 | 4 |
_aUbiquitin-Protein Ligases _xgenetics |
| 700 | 1 | _aPapakosta, Vasiliki | |
| 700 | 1 | _aMiranda, Adriana Viola | |
| 700 | 1 | _aZacharopoulou, Lefkothea | |
| 700 | 1 | _aDanilchenko, Valeriia | |
| 700 | 1 | _aMatiashova, Lolita | |
| 700 | 1 | _aDhar, Amrit | |
| 773 | 0 |
_tCurrent gene therapy _gvol. 19 _gno. 6 _gp. 359-366 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.2174/1566523220666200107151025 _zAvailable from publisher's website |
| 999 |
_c30496627 _d30496627 |
||